These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27753040)

  • 1. Evaluation of Different Blood Collection Tubes and Blood Storage Conditions for the Preservation and Stability of Cell-Free Circulating DNA for the Analysis of the Methylated
    Distler J; Tetzner R; Weiss G; König T; Schlegel A; Bagrowski M
    Adv Exp Med Biol; 2016; 924():175-178. PubMed ID: 27753040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
    Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
    PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
    Medina Diaz I; Nocon A; Mehnert DH; Fredebohm J; Diehl F; Holtrup F
    PLoS One; 2016; 11(11):e0166354. PubMed ID: 27832189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
    Ladabaum U; Allen J; Wandell M; Ramsey S
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker].
    Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Leiszter K; Molnár J; Molnár B; Tulassay Z
    Orv Hetil; 2009 May; 150(21):969-77. PubMed ID: 19443305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
    Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
    Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene.
    Leon Arellano M; García-Arranz M; Ruiz R; Olivera R; Magallares S; Olmedillas-Lopez S; Valdes-Sanchez T; Guadalajara H; García-Olmo D
    Dis Markers; 2020; 2020():9761406. PubMed ID: 32566042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma methylated septin 9: a colorectal cancer screening marker.
    Molnár B; Tóth K; Barták BK; Tulassay Z
    Expert Rev Mol Diagn; 2015 Feb; 15(2):171-84. PubMed ID: 25429690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients.
    Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL
    World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors.
    Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y
    Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
    Payne SR
    Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
    Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
    Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
    Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
    Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
    Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.